These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 37986235)

  • 1. Mobile vaccination units substantially increase COVID-19 vaccinations: evidence from a randomized controlled trial.
    Kulle AC; Schumacher S; von Bieberstein F
    J Public Health (Oxf); 2024 Feb; 46(1):151-157. PubMed ID: 37986235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of using mobile vaccination units to increase COVID-19 vaccination uptake in Cheshire and Merseyside, UK: a synthetic control analysis.
    Zhang X; Tulloch JSP; Knott S; Allison R; Parvulescu P; Buchan IE; Garcia-Finana M; Piroddi R; Green MA; Baird S; Barr B
    BMJ Open; 2023 Oct; 13(10):e071852. PubMed ID: 37802621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
    Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
    JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nudging COVID-19 Vaccine Uptake by Changing the Default: A Randomized Controlled Trial.
    Tentori K; Pighin S; Giovanazzi G; Grignolio A; Timberlake B; Ferro A
    Med Decis Making; 2022 Aug; 42(6):837-841. PubMed ID: 35658775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaching Diverse Communities During a Local Public Health COVID-19 Vaccination Response Through a Mobile Clinic Compared to Mass Vaccination Sites.
    Gavin RM; Countryman M; Musco J; Ricard R; Roberts A; Lees C
    J Public Health Manag Pract; 2024 May-Jun 01; 30(3):411-415. PubMed ID: 38603747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving pediatric COVID-19 vaccine uptake using an mHealth tool (MoVeUp): study protocol for a randomized, controlled trial.
    McCulloh RJ; Darden PM; Snowden J; Ounpraseuth S; Lee J; Clarke M; Newcomer SR; Fu L; Hubberd D; Baldner J; Garza M; Kerns E
    Trials; 2022 Oct; 23(1):911. PubMed ID: 36307830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to increase COVID-19 vaccination among a population with persistently suboptimal vaccine uptake? Evidence from the North Macedonia mobile vaccination and public health advice caravan.
    Serrano-Alarcón M; Mckee M; Palumbo L; Salvi C; Johansen A; Stuckler D
    Health Policy; 2024 Jan; 139():104966. PubMed ID: 38101148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Fiebelkorn AP
    MMWR Surveill Summ; 2017 May; 66(11):1-28. PubMed ID: 28472027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual immunisation coverage report 2021.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine hesitancy in rural South Africa: Deepening understanding to increase uptake and access.
    Kahn K; Pettifor A; Mataboge P; Kelly NK; Mashinini DP; Nair H; Campbell H; Cohen C; Gómez-Olivé FX; Tollman S
    J Glob Health; 2022 May; 12():05013. PubMed ID: 35567586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding COVID-19 vaccine access to underserved populations through implementation of mobile vaccination units.
    Gupta PS; Mohareb AM; Valdes C; Price C; Jollife M; Regis C; Munshi N; Taborda E; Lautenschlager M; Fox A; Hanscom D; Kruse G; LaRocque R; Betancourt J; Taveras EM
    Prev Med; 2022 Oct; 163():107226. PubMed ID: 36029925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
    Poh XY; Lee IR; Lim C; Teo J; Rao S; Chia PY; Ong SWX; Lee TH; Lin RJH; Ng LFP; Ren EC; Lin RTP; Wang LF; Renia L; Lye DC; Young BE
    Trials; 2022 Jun; 23(1):498. PubMed ID: 35710572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Location Intelligence to Evaluate the COVID-19 Vaccination Campaign in the United States: Spatiotemporal Big Data Analysis.
    Li Q; Peng JC; Mohan D; Lake B; Euler AR; Weir B; Kan L; Yang C; Labrique A
    JMIR Public Health Surveill; 2023 Feb; 9():e39166. PubMed ID: 36626835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monetary incentives increase COVID-19 vaccinations.
    Campos-Mercade P; Meier AN; Schneider FH; Meier S; Pope D; Wengström E
    Science; 2021 Nov; 374(6569):879-882. PubMed ID: 34618594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.